Floatz logo

Viosterol

Bone Fracture

Brigham and Women's HospitalSmall moleculeUnknownDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Bone Fracture cohort.

Asset / SponsorPhaseRating
RISEDRONIC ACID
Boston VA Research Institute, Inc.
Phase 4BB
Calcium
Boston VA Research Institute, Inc.
Phase 4BB
VITAMIN D
Boston VA Research Institute, Inc.
Phase 4BB
Sufentanyl
West Virginia University
Phase 4BB
TOREMIFENE
GTx
Phase 3BB
Zoledronate
GlaxoSmithKline
Phase 3B
Denosumab
GlaxoSmithKline
Phase 3B
Dalteparin
M.D. Anderson Cancer Center
N/ANR

Same molecule, other indications

Viosterol is also rated in:

secondary hyperparathyroidismDormant
BB
Indicative · Phase 4
64 / 100
View asset →
impaired renal function diseaseDormant
B
Indicative · Phase 3
61 / 100
View asset →
essential hypertensionDormant
B
Indicative · Phase 3
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →